Institute of Neuroscience and Psychology, West Medical Building, University Avenue, University of Glasgow, Glasgow, G12 8QQ, UK.
Neuroscience. 2011 Sep 29;192(6-2):708-20. doi: 10.1016/j.neuroscience.2011.07.011. Epub 2011 Jul 14.
Nitric oxide produced by neuronal nitric oxide synthase (nNOS) in the spinal cord is required for development of hyperalgesia in inflammatory and neuropathic pain states. nNOS is expressed by some dorsal horn neurons, and an early study that used a histochemical method to identify these cells suggested that they were mainly inhibitory interneurons. We have carried out a quantitative analysis of nNOS-immunoreactivity in laminae I-III of the rat dorsal horn, to determine the proportion of inhibitory and excitatory neurons and axonal boutons that express the protein. nNOS was present in ∼5% of neurons in laminae I and III, and 18% of those in lamina II. Although most cells with strong nNOS immunostaining were GABA-immunoreactive, two-thirds of the nNOS-positive cells in lamina II and half of those in lamina III were not GABAergic, and some of these expressed protein kinase Cγ (PKCγ). We estimate that nNOS is present in 17-19% of the inhibitory interneurons in laminae I-II, and 6% of those in lamina III. However, our results suggest that nNOS is also expressed at a relatively low level by a significant proportion (∼17%) of excitatory interneurons in lamina II. nNOS was seldom seen in boutons that contained vesicular glutamate transporter 2, which is expressed by excitatory interneurons, but was co-localised with the vesicular GABA transporter (VGAT, a marker for GABAergic and glycinergic axons). nNOS was detected in 13% of VGAT boutons in lamina I and in 7-8% of those in laminae II-III. However, it was only found in 2-4% of the VGAT boutons that were presynaptic to PKCγ-expressing interneurons in this region. These results indicate that nNOS is more widely expressed than previously thought, being present in both inhibitory and excitatory neurons. They provide further evidence that axons of neurochemically defined populations of inhibitory interneuron are selective in their post-synaptic targets.
脊髓神经元型一氧化氮合酶(nNOS)产生的一氧化氮是炎症性和神经性疼痛状态下痛觉过敏发展所必需的。nNOS 由一些背角神经元表达,一项早期使用组织化学方法来识别这些细胞的研究表明,它们主要是抑制性中间神经元。我们对大鼠背角 I-III 层中的 nNOS 免疫反应进行了定量分析,以确定表达该蛋白的抑制性和兴奋性神经元和轴突末梢的比例。nNOS 存在于 I 层和 III 层中约 5%的神经元中,在 II 层中存在 18%。尽管大多数具有强 nNOS 免疫染色的细胞是 GABA 免疫反应性的,但 II 层中三分之二的 nNOS 阳性细胞和 III 层中一半的 nNOS 阳性细胞不是 GABA 能的,其中一些表达蛋白激酶 Cγ(PKCγ)。我们估计,nNOS 存在于 I-II 层中的 17-19%的抑制性中间神经元中,存在于 III 层中的 6%。然而,我们的结果表明,nNOS 也以相对较低的水平表达在 II 层中相当大比例(约 17%)的兴奋性中间神经元中。nNOS 很少见于含有囊泡谷氨酸转运体 2(表达兴奋性中间神经元)的末梢,但与囊泡 GABA 转运体(VGAT,GABA 能和甘氨酸能轴突的标志物)共定位。在 I 层中的 13%的 VGAT 末梢和 II-III 层中的 7-8%的 VGAT 末梢中检测到 nNOS。然而,它仅在该区域中表达 PKCγ 的中间神经元的 VGAT 末梢的 2-4%中被发现。这些结果表明,nNOS 的表达比以前认为的更为广泛,存在于抑制性和兴奋性神经元中。它们提供了进一步的证据,表明神经化学定义的抑制性中间神经元群体的轴突在其突触后靶标中具有选择性。